Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proadrenomedullin as a Severity Score and Prognostic Marker in Intra-abdominal Sepsis

NCT03061500 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.

NCT NCT03061500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03061500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proadrenomedullin as a Severity Score and Prognostic Marker in Intra-abdominal Sepsis
Lead sponsor
Instituto de Investigación Hospital Universitario La Paz
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2016
Completion date
October 15, 2017
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraabdominal infections